The National Ataxia Foundation aims to support cutting-edge Ataxia research to find a cure and improve the quality of life for those affected by hereditary and sporadic forms of Ataxia.
NAF is dedicated to supporting Ataxia research by providing funding for scientific studies aimed at understanding hereditary and sporadic types of Ataxia. Their grant programs welcome applications from both non-profit and for-profit institutions globally, with specific opportunities for research focused on Spinocerebellar Ataxia Type 3 (SCA3). These grants seek to advance treatment development and improve patient care, with the Pioneer SCA3 Translational Research Award offering up to $100,000 for exceptional proposals. Non-U.S. citizens are encouraged to apply, indicating an inclusive approach to worldwide research collaboration.
cupidatat dolor consequat nisi adipisicing officia dolore eiusmod Lorem ex pariatur fugiat